Albaracin, Kurt Jan S.
HRN: 10-06-38 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/05/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/05/2024
01/12/2024
IV
500mg
Q8H
T/C POST OP ADHESIONS
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes